Abstract:Ubiquitin-like proteins (UBLs) constitute a family of evolutionarily conserved proteins that share similarities with ubiquitin in 3D structures and modification mechanisms. For most UBLs including Small-Ubiquitin-like Modifiers (SUMO), their modification sites on substrate proteins cannot be identified using the mass spectrometry-based method that has been successful for identifying ubiquitination sites, unless a UBL protein is mutated accordingly. To identify UBL modification sites without having to mutate UBL, we have developed a dedicated search engine pLink-UBL on the basis of pLink, a software tool for identification of cross-linked peptide pairs. pLink-UBL exhibited superior precision, sensitivity, and speed than make-do search engines such as MaxQuant, pFind, and pLink. For example, compared to MaxQuant, pLink-UBL increased the number of identified SUMOylation sites by 50 ~ 300% from the same datasets. Additionally, we present a method for identifying small-molecule modifications of UBLs. This method involves antibody enrichment of a UBL C-terminal peptide following enrichment of a UBL protein, followed by LC-MS/MS analysis and a pFind 3 blind search to identify unexpected modifications. Using this method, we have discovered non-protein substrates of SUMO, of which spermidine is the major one for fission yeast SUMO Pmt3. Spermidine can be conjugated to the C-terminal carboxylate group of Pmt3 through its N1 or also likely, N8 amino group in the presence of SUMO E1, E2, and ATP. Pmt3-spermidine conjugation does not require E3 and can be reversed by SUMO isopeptidase Ulp1. SUMO-spermidine conjugation is present in mice and humans. Also, spermidine can be conjugated to ubiquitin in vitro by E1 and E2 in the presence of ATP. The above observations suggest that spermidine may be a common small molecule substrate of SUMO and possibly ubiquitin across eukaryotic species.

Biochemical and Mass Spectrometry-Based Approaches to Profile SUMOylation in Human Cells.

The Strategies for Identification and Quantification of SUMOylation

Ms-Based Strategies For Identification Of Protein Sumoylation Modification

Site-specific identification and quantitation of endogenous SUMO modifications under native conditions

Dissecting the Ubiquitin Pathway by Mass Spectrometry.

Antibody-free enrichment method for proteome-wide analysis of endogenous SUMOylation sites

Protein modification by SUMO.

SUMO conjugation – a mechanistic view

A genome-wide analysis of sumoylation-related biological processes and functions in human nucleus.

Proteomic identification of protein ubiquitination events

Q 7 A Progress in SUMO modification research

Highly Sensitive Assays for SUMOylation and Small Ubiquitin-Like Modifier-Dependent Protein–protein Interactions

A Method For Sumo Modification Of Proteins In Vitro

Identification and analysis of endogenous SUMO1 and SUMO2/3 targets in mammalian cells and tissues using monoclonal antibodies

Protein SUMOylation Modification and Its Associations with Disease

Visualizing and quantifying protein polySUMOylation at the single-molecule level.

Ubiquitinated Proteome: Ready for Global?

A Turn-Key Approach for Large-Scale Identification of Complex Posttranslational Modifications.

Sensitive detection of intracellular sumoylation via SNAP tag-mediated translation and RNA polymerase-based amplification.

Global analysis of protein and small-molecule substrates of ubiquitin-like proteins (UBLs)

Putative Role of Sumoylation in Controlling the Activity of Deubiquitinating Enzymes in Cancer